A diagnosis of MPS IVA typically follows specific steps: clinical assessment of the symptoms, glycosaminoglycans analysis in urine, GALNS activity determination in patients with high concentrations of urine keratin sulfates, genetic confirmation of the biochemical analysis. The gene discussed is GALNS; the disease is mucopolysaccharidosis type 4A.